
AstraZeneca, Zero Prostate Cancer rev up early detection push at Memorial Day weekend NASCAR races
AstraZeneca is putting the pedal to the metal to drive up early detection of prostate cancer. The British pharma—which sells Lynparza as a prostate cancer treatment and is also testing its Truqap in the disease—has teamed up with advocacy organization Zero …